CN103340936A - Traditional Chinese medicine for treating primary gout - Google Patents
Traditional Chinese medicine for treating primary gout Download PDFInfo
- Publication number
- CN103340936A CN103340936A CN2013102902509A CN201310290250A CN103340936A CN 103340936 A CN103340936 A CN 103340936A CN 2013102902509 A CN2013102902509 A CN 2013102902509A CN 201310290250 A CN201310290250 A CN 201310290250A CN 103340936 A CN103340936 A CN 103340936A
- Authority
- CN
- China
- Prior art keywords
- gout
- parts
- medicine
- primary gout
- treating primary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine which is used for treating primary gout and prepared from Chinese herbal medicine raw materials. The medicine for treating primary gout is characterized by being powder, pill and soup prepared from the following Chinese herbal medicines in parts by weight: 10-25 parts of semen plantaginis, 10-25 parts of christina loosestrife herb, 8-17 parts of rhizoma cibotii, 10-20 parts of radix astragali, 5-15 parts of liquorice and 20-25 parts of ganoderma lucidum.
Description
Technical field
The invention belongs to treatment primary gout field, being specifically related to a kind of Chinese herbal medicine is powder, pill, the decoction that raw material is made the treatment primary gout.
Background technology
One, the present situation of gout:
Gout is distributed in all over the world, is subjected to race, diet, drinks, multifactor impacts such as occupation, environment and schooling.The prevalence of European and American areas gout is 0.2%-1.7%.In China, the sickness rate of gout is in rising trend in recent years, and China's general population's prevalence is about 1.14%, and wherein Taiwan and area, Qingdao are the gout districts occurred frequently, Taiwan aborigines' prevalence about 11.7% more than 18 years old.The generation of gout is relevant with sex and age, is more common in middle-aged and elderly people, accounts for 90%, and the onset peak age is 40-50 year, and M-F is about 20: 1.According to the statistics of national authority department, China has how 120 ten thousand patient with gout at present approximately, and annual with thousands of speed increases!
Two, the reason of gout:
The reason that causes gout is very complicated.Doctor trained in Western medicine thinks that the most important biochemical basis of gout is hyperuricemia.Normal adult produces uric acid 750mg every day approximately, wherein 80% is endogenous, 20% is exogenous uric acid, wherein 1/3 about 200mg is through intestinal catabolism, 2/3 about 400mg is through renal excretion, thereby can keep the stable of the interior uric acid level of body, wherein any link goes wrong and all can cause hyperuricemia.Its cause of disease comprises:
Primary gout: heritability is arranged more, but clinically have gout family history person only to account for 10%-20%.Uricopoiesis too much accounts for 10% in the cause of disease of primary hyperuricemia.Its reason mainly is the purine metabolism enzyme defect, and hypoxanthine guanine phosphoribosyltransferase (HGPRT) shortage and phosphoribosylpyrophosphate salt (PRPP) synthase activity are hyperfunction.The minimizing of constitutional kidney urate excretion accounts for 90% of primary hyperuricemia, and concrete pathogenesis is unclear.
Secondary gout: refer to be secondary to a kind of clinical manifestation in the other diseases process, also can be because of due to the some drugs.
Primary gout lacks etiological treatment, can not effect a radical cure.At present, clinically be used for treating the primary gout medicine, comprise (1) nonsteroidal anti-inflammatory agent, this type of medicine common adverse effect is the untoward reaction of gastrointestinal symptom and cardiovascular system; (2) colchicine: be the conventional medicament for the treatment of acute attack, its untoward reaction is more, mainly is gastrointestinal reaction, also can cause bone marrow depression, hepatic injury, allergy and neurotoxicity etc.; (3) glucocorticoid: the treatment acute gout has obvious curative effects, is generally used for tolerating nonsteroidal anti-inflammatory agent and colchicine or renal insufficiency person, has symptom " knock-on " after more systemic adverse reactions and the drug withdrawal usually.Tcm clinical practice does not have powder, pill, the decoction for the treatment of primary gout as yet.
Three, summary of the invention:
Purpose of the present invention is exactly to provide a kind of to regulate the inherent physiological function of human body, harmless at above-mentioned weak point, and the respond well medicine for the treatment of primary gout.
Technical solution of the present invention is: a kind of primary gout medicine for the treatment of is characterized in that it is powder, pill, the decoction of being made by the Chinese herbal medicine of following weight parts proportioning:
Semen Plantaginis 10-25 Herba Lysimachiae 10-25 gold Rhizoma Cibotii 8-17
Radix Astragali 10-20 Radix Glycyrrhizae 5-15 Ganoderma lucidum seu Japonicum 20-25
Important feature of the present invention is rich nutrient contents in the medicament, and each raw material components ingredient of the present invention and function cure mainly as follows:
Semen Plantaginis: contain Geniposidic acid and verbascoside.Function with cure mainly: clearing away heat and promoting diuresis is treating stranguria.
Herba Lysimachiae: contain Cortex querci dentatae and mountain element.Function with cure mainly: dampness removing, inducing diuresis for treating stranguria syndrome.
The gold Rhizoma Cibotii: function with cure mainly: the replenishing vital QI with drugs of warm nature Liver and kidney, logical hundred arteries and veins of transferring, strong waist knee joint, hard spine, sharp joint, and drive the numbness work, strong superintending and directing appointed. and temperature and not dry, walk and do not let out.
Radix Astragali: contain astragaloside and calycosin glycoside, function with cure mainly: tonifying Qi and lifting yang, benefit is defended consolidating superficial resistance, the diuretic detumescent.
Radix Glycyrrhizae: the root of Radix Glycyrrhizae and rhizome contain the triterpenoid saponin glycyrrhizic acid, i.e. glycyrrhizin, be enoxolone (glucosulfone aldehydic acid glycoside, be the sweet taste composition of Radix Glycyrrhizae.Still tell the biosone in the hydrolyzate of licorice, this thing is verified to be the 18a-enoxolone.Also telling the multiple flavone component from the Radix Glycyrrhizae rhizome has glycyrrhizin, isoliquiritigenin, liquiritin, neoliquriitin, neoisoliquiritin etc.Homemade Radix Glycyrrhizae sample analysis result: hydrotrope 18.7-40.54%, glycyrrhizic acid 3.63-13.06%, reducing sugar 3.38-13.67%, starch and colloid 2.04-6.32%, moisture 6.04-8.44%, ash 3.35-6.68%.
Ganoderma lucidum seu Japonicum: Ganoderma contains ergosterol (Ergosterol), organic acid, (ricinic acid, court of a feudal ruler fumarate etc.), glucosamine, polysaccharide, resin, mannitol etc.Ganoderma lucidum (Leyss. Ex Fr.) Karst. contains that ergosterol, tree refer to, fatty acid, mannitol and polysaccharide; Contain alkaloid, lactone, coumarin, water soluble protein and multiple enzyme again.
Example 1:
The treatment primary gout:
Assort the golden Rhizoma Cibotii 85 gram Radix Astragali of Semen Plantaginis 50 gram Herba Lysimachiaes 50 grams 50 gram Radix Glycyrrhizaes 50 kairine Ganoderma lucidum seu Japonicum 100 grams, be distributed into decoction, 100 milliliters every bag after frying in shallow oil with boiling machine.
Former patient Tang, ancient Chinese prose township Ya in Dahua Yao Nationality Autonomous County's closes people from village, the man, 66 years old, be diagnosed as primary gout through the People's Hospital, Dahua Yao Nationality Autonomous County, blood uric acid concentration remains between the 488-640 μ mol/L for a long time; The doctor's advice period in a medicine advances to hang down the purine low-calorie diet in advance, alleviating alcohol addiction, polydipsia water is drunk water more than the 2000ml every day, avoid gluttony, indulge in excessive drinking, suffer from cold make moist, overtired and psychentonia, above medicine is given the patient, the next day that instructions of taking being one bag, check that to the People's Hospital, Dahua Yao Nationality Autonomous County blood uric acid is 426 μ mol/L after serveing on 3 months, obeyed one month, blood uric acid drops to 360 μ mol/L again.
Example 2:
The treatment primary gout:
Assort the golden Rhizoma Cibotii 200 gram Radix Astragali of Semen Plantaginis 100 gram Herba Lysimachiaes 100 grams 130 gram Radix Glycyrrhizaes 180 kairine Ganoderma lucidum seu Japonicum 200 grams, be distributed into decoction, 120 milliliters every bag after frying in shallow oil with boiling machine.
Former patient land, the south of the River, Dahua Yao Nationality Autonomous County township reaches people from village, the man, 59 years old, be diagnosed as primary gout through the People's Hospital, Dahua Yao Nationality Autonomous County, blood uric acid concentration remains between the 576-760 μ mol/L for a long time; The doctor's advice period in a medicine advances to hang down the purine low-calorie diet in advance, alleviating alcohol addiction, polydipsia water is drunk water more than the 2000ml every day, avoid gluttony, indulge in excessive drinking, suffer from cold make moist, overtired and psychentonia, above medicine is given the patient, instructions of taking is one bag of every day, serve on after two months to check that to the People's Hospital, Dahua Yao Nationality Autonomous County blood uric acid is 538 μ mol/L, obeyed two months, blood uric acid drops to 358 μ mol/L again.
Claims (1)
1. the invention belongs to treatment primary gout technical field, being specifically related to a kind of Chinese herbal medicine is that raw material is made treatment primary gout medicine, it is characterized in that it is powder, pill, the decoction of being made by the Chinese herbal medicine of following weight parts proportioning: Semen Plantaginis 10-25 Herba Lysimachiae 10-25 gold Rhizoma Cibotii 8-17 Radix Astragali 10-20 Radix Glycyrrhizae 5-15 Ganoderma lucidum seu Japonicum 20-25.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013102902509A CN103340936A (en) | 2013-07-11 | 2013-07-11 | Traditional Chinese medicine for treating primary gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013102902509A CN103340936A (en) | 2013-07-11 | 2013-07-11 | Traditional Chinese medicine for treating primary gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103340936A true CN103340936A (en) | 2013-10-09 |
Family
ID=49275796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013102902509A Pending CN103340936A (en) | 2013-07-11 | 2013-07-11 | Traditional Chinese medicine for treating primary gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103340936A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104398564A (en) * | 2014-11-14 | 2015-03-11 | 成都医路康医学技术服务有限公司 | Tripterygium wilfordii containing Chinese medicinal composition for treatment of gout |
| CN106511498A (en) * | 2016-12-21 | 2017-03-22 | 四川何天祺医院管理有限公司 | Pharmaceutical composition for treating gout and bone diseases |
| CN108938961A (en) * | 2018-10-09 | 2018-12-07 | 乐清市足资初生物科技有限公司 | A kind of Tea containing traditional Chinese medicine and preparation method thereof for treating gout |
| CN109172670A (en) * | 2018-11-13 | 2019-01-11 | 张洪搏 | Chinese medicine composition and preparation method thereof with liver kidney Metabolism regulation function |
| CN116474038A (en) * | 2023-05-23 | 2023-07-25 | 广州梓兴医疗科技有限公司 | Traditional Chinese medicine composition for treating gout and preparation method thereof |
-
2013
- 2013-07-11 CN CN2013102902509A patent/CN103340936A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| LINGZHI315: "灵芝调节尿酸、改善痛风", 《HTTP://WWW.LINGZHI315.BOKEE.NET/COMPANY/WEBLOG_VIEWENTRY/8511890.HTML》 * |
| YANBOGOLF: "治尿酸配方", 《HTTP://WENKU.BAIDU.COM/VIEW/79E3D0482B160B4E767FCFC7.HTML》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104398564A (en) * | 2014-11-14 | 2015-03-11 | 成都医路康医学技术服务有限公司 | Tripterygium wilfordii containing Chinese medicinal composition for treatment of gout |
| CN106511498A (en) * | 2016-12-21 | 2017-03-22 | 四川何天祺医院管理有限公司 | Pharmaceutical composition for treating gout and bone diseases |
| CN106511498B (en) * | 2016-12-21 | 2020-02-14 | 四川何天祺医院管理有限公司 | Pharmaceutical composition for treating gout and bone diseases |
| CN108938961A (en) * | 2018-10-09 | 2018-12-07 | 乐清市足资初生物科技有限公司 | A kind of Tea containing traditional Chinese medicine and preparation method thereof for treating gout |
| CN109172670A (en) * | 2018-11-13 | 2019-01-11 | 张洪搏 | Chinese medicine composition and preparation method thereof with liver kidney Metabolism regulation function |
| CN116474038A (en) * | 2023-05-23 | 2023-07-25 | 广州梓兴医疗科技有限公司 | Traditional Chinese medicine composition for treating gout and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sweeney et al. | Evidence-based systematic review of dandelion (Taraxacum officinale) by natural standard research collaboration | |
| CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
| CN103340936A (en) | Traditional Chinese medicine for treating primary gout | |
| CN103071048A (en) | Traditional Chinese medicine composition for treating alzheimer diseases and preparation method of traditional Chinese medicine composition | |
| CN101264205A (en) | Chinese medicinal composition for treating gout and preparation thereof | |
| CN101607074A (en) | A kind of drug regimen for the treatment of chronic gastritis and preparation method thereof | |
| CN101837087B (en) | Chinese medicinal composition for improving immunity, resisting fatigue and improving sexual function | |
| CN105287812B (en) | A kind of medical composition and its use for treating irritable bowel syndrome | |
| CN103933487A (en) | Compound traditional Chinese medicament for treating depression | |
| CN101406598B (en) | Chinese medicine composite for treating diabetes and preparation method thereof | |
| CN101524441A (en) | Chinese medicinal composition for lipid-lowering and weight-losing and preparation method thereof | |
| CN103655786B (en) | A kind of Chinese medicine composition for the treatment of hyperuricemia and gout | |
| CN106539908A (en) | A kind of Chinese medicine composition for treating allergic rhinitises and skin allergy | |
| CN101708231A (en) | Blood pressure and blood fat reducing oral liquid used for improving sleep quality and preparation method thereof | |
| CN104721256A (en) | Anwei Yang extract as well as preparation method and medical application thereof | |
| CN101623455B (en) | Medicine for treating prostate hyperplasia | |
| CN105327115B (en) | A kind of prevention and treatment type II diabetes Phellinus is logical to rush down formula and preparation process | |
| CN104257839B (en) | A kind of Chinese medicine composition with hypoglycemic protection blood vessel endothelium effect and preparation method thereof | |
| CN103705812B (en) | A kind of pharmaceutical composition for the treatment of gout and its production and use | |
| CN102366506A (en) | Traditional Chinese medicine composition for treating idiopathic edema | |
| CN105194355A (en) | Traditional Chinese medicine preparation for treating primary hypertension | |
| CN104758578A (en) | Traditional Chinese medicine composition for treating palpitation | |
| CN104127787A (en) | Traditional Chinese medicinal plaster for treating constipations | |
| CN103721083B (en) | A kind of pharmaceutical composition for gestational vulvareczema | |
| CN103285193A (en) | Lung-tonifying capsule for treating lung-distension caused by qi deficiency of lung and kidney and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131009 |